Correction to: Efficacy and safety of ixekizumab in patients with active psoriatic arthritis with and without concomitant conventional disease-modifying antirheumatic drugs: SPIRIT-P1 and SPIRIT-P2 3-year results
Crossref DOI link: https://doi.org/10.1007/s10067-022-06271-3
Published Online: 2022-07-11
Published Print: 2022-10
Update policy: https://doi.org/10.1007/springer_crossmark_policy
Coates, Laura C.
Mease, Philip
Kronbergs, Andris
Helt, Cameron
Sandoval, David
Park, So Young
Combe, Bernard
Nash, Peter
Deodhar, Atul http://orcid.org/0000-0002-2130-1246
Text and Data Mining valid from 2022-07-11
Version of Record valid from 2022-07-11
Article History
First Online: 11 July 2022